Personalized Weight Management at Dr
Introducing retatrutide Retatrutide is a new medication that targets the glucose-dependent insulinotropic polypeptide (GIP receptor), glucagon-like peptide-1 (GLP-1), and glucagon receptors (GCG receptors)
How to break through Resistance training: Building and maintaining muscle through weight lifting or bodyweight exercises protects your metabolism from slowing down
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk - Full Text View - ClinicalTrials.gov
In the context of weight loss, compounded versions of tirzepatide or semaglutide may be offered when branded medications are unavailable, backordered, or cost-prohibitive
For now, the findings provide early evidence that the fertility conversation surrounding GLP-1 medications may be more nuanced than previously thought.